Cite

HARVARD Citation

    Schirosi, L. et al. (2016). Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?. BMC cancer. 16 (1), pp. 1-11. [Online]. 
  
Back to record